Kumar Ilangovan

976 total citations · 1 hit paper
13 papers, 232 citations indexed

About

Kumar Ilangovan is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, Kumar Ilangovan has authored 13 papers receiving a total of 232 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 3 papers in Infectious Diseases and 3 papers in Oncology. Recurrent topics in Kumar Ilangovan's work include Respiratory viral infections research (6 papers), Global Cancer Incidence and Screening (3 papers) and Viral gastroenteritis research and epidemiology (2 papers). Kumar Ilangovan is often cited by papers focused on Respiratory viral infections research (6 papers), Global Cancer Incidence and Screening (3 papers) and Viral gastroenteritis research and epidemiology (2 papers). Kumar Ilangovan collaborates with scholars based in United States, United Kingdom and Italy. Kumar Ilangovan's co-authors include Elliot C. Pennington, E. Brooke Lerner, Manish N. Shah, Rollin J. Fairbanks, Sandra M. Schneider, Tulay Koru‐Sengul, Olveen Carrasquillo, Eric G. Poon, Carolyn A. Hutyra and Armando Bedoya and has published in prestigious journals such as Clinical Infectious Diseases, Medical Care and Vaccine.

In The Last Decade

Kumar Ilangovan

10 papers receiving 224 citations

Hit Papers

Efficacy, Immunogenicity, and Safety of the Bivalent Resp... 2025 2026 2025 4 8 12
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy, Immunogenicity, and Safety of the Bivalent Respiratory Syncytial Virus (RSV) Prefusion F Vaccine in Older Adults Over 2 RSV Seasons
    2025 14 citations Edward E. Walsh, Daniel Eiras et al. Clinical Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kumar Ilangovan United States 8 91 66 46 33 26 13 232
Yuliya Pinevich United States 9 45 0.5× 36 0.5× 11 0.2× 30 0.9× 40 1.5× 22 214
Christine Rutan United States 11 71 0.8× 21 0.3× 62 1.3× 17 0.5× 14 0.5× 18 261
Serena Sibilio Italy 9 76 0.8× 111 1.7× 12 0.3× 11 0.3× 35 1.3× 44 260
Alex Novak United Kingdom 6 46 0.5× 60 0.9× 42 0.9× 8 0.2× 17 0.7× 29 205
Simon Swift United Kingdom 6 34 0.4× 102 1.5× 14 0.3× 14 0.4× 24 0.9× 8 238
James Malycha Australia 8 128 1.4× 86 1.3× 6 0.1× 14 0.4× 17 0.7× 17 232
Tom Palser United Kingdom 10 29 0.3× 36 0.5× 59 1.3× 23 0.7× 23 0.9× 12 280
Xuedi Ma China 4 24 0.3× 90 1.4× 49 1.1× 24 0.7× 6 0.2× 8 271
Yasir Tarabichi United States 10 61 0.7× 19 0.3× 70 1.5× 46 1.4× 4 0.2× 29 359
Vishakha K. Kumar United States 7 36 0.4× 18 0.3× 24 0.5× 30 0.9× 5 0.2× 28 226

Countries citing papers authored by Kumar Ilangovan

Since Specialization
Citations

This map shows the geographic impact of Kumar Ilangovan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kumar Ilangovan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kumar Ilangovan more than expected).

Fields of papers citing papers by Kumar Ilangovan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kumar Ilangovan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kumar Ilangovan. The network helps show where Kumar Ilangovan may publish in the future.

Co-authorship network of co-authors of Kumar Ilangovan

This figure shows the co-authorship network connecting the top 25 collaborators of Kumar Ilangovan. A scholar is included among the top collaborators of Kumar Ilangovan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kumar Ilangovan. Kumar Ilangovan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Walsh, Edward E., Daniel Eiras, John Woodside, et al.. (2025). Efficacy, Immunogenicity, and Safety of the Bivalent Respiratory Syncytial Virus (RSV) Prefusion F Vaccine in Older Adults Over 2 RSV Seasons. Clinical Infectious Diseases. 81(6). e680–e689. 14 indexed citations breakdown →
2.
Ilangovan, Kumar, David Radley, Michael A. Patton, et al.. (2025). Integrated Analysis of the Safety Experience in Adults with the Bivalent Respiratory Syncytial Virus Prefusion F Vaccine. Vaccines. 13(8). 827–827. 1 indexed citations
3.
Mikati, Tarek, Yasushi Fukushima, Daniel Eiras, et al.. (2025). P-605. Bivalent RSV Prefusion F-Based Subunit Vaccine Generates High and Durable Neutralizing Titers Across an Entire RSV Season among Older Adults. Open Forum Infectious Diseases. 12(Supplement_1).
4.
Williams, S., Bradford D. Gessner, Elizabeth Begier, et al.. (2024). Is a Consensus Case Definition for Viral Associated Lower Respiratory Tract Disease (LRTD) in Clinical Trials Possible?. Infectious Diseases and Therapy. 14(1). 1–11. 1 indexed citations
5.
Fukushima, Yasushi, José F. Cardona, Agnieszka Zareba, et al.. (2023). 1632. Bivalent RSV Prefusion F-Based Subunit Vaccine Generates High Neutralizing Titers in Older Adults. Open Forum Infectious Diseases. 10(Supplement_2).
6.
Bouguermouh, Salim, Kumar Ilangovan, Michael W. Pride, et al.. (2023). A phase 3 study evaluating the lot consistency, immunogenicity, safety, and tolerability of a Clostridioides difficile vaccine in healthy adults 65 to 85 years of age. Vaccine. 41(50). 7548–7559. 9 indexed citations
7.
Marc, Gonzalo Pérez, Edward E. Walsh, Elliot DeHaan, et al.. (2023). 1630. Clinical Profile of Acute Respiratory Illness (ARI) Events in the Phase 3 Trial The RSV Vaccine Efficacy Study iN Older Adults Immunized against RSV Disease (RENOIR). Open Forum Infectious Diseases. 10(Supplement_2).
8.
9.
Ilangovan, Kumar, et al.. (2016). Acceptability and Feasibility of Human Papilloma Virus Self-Sampling for Cervical Cancer Screening. Journal of Women s Health. 25(9). 944–951. 40 indexed citations
10.
Martinez, Iveris L., et al.. (2016). Breast Health Disparities: A Primer for Medical Students. MedEdPORTAL. 12. 10471–10471. 7 indexed citations
11.
Chang, Aileen Y., Sonjia Kenya, Kumar Ilangovan, et al.. (2015). Is Greater Acculturation Associated With an Increased Prevalence of Cardiovascular Risk Factors Among Latinos in South Florida?. Medical Care. 53(5). 417–422. 11 indexed citations
12.
13.
Fairbanks, Rollin J., Manish N. Shah, E. Brooke Lerner, et al.. (2006). Epidemiology and outcomes of out-of-hospital cardiac arrest in Rochester, New York. Resuscitation. 72(3). 415–424. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuliya Pinevich Breakdown of academic impact, for papers by Christine Rutan Breakdown of academic impact, for papers by Serena Sibilio Breakdown of academic impact, for papers by Alex Novak Breakdown of academic impact, for papers by Simon Swift Breakdown of academic impact, for papers by James Malycha Breakdown of academic impact, for papers by Tom Palser Breakdown of academic impact, for papers by Xuedi Ma Breakdown of academic impact, for papers by Yasir Tarabichi Breakdown of academic impact, for papers by Vishakha K. Kumar
Rankless by CCL
2026